Page last updated: 2024-10-25

cimetidine and Inflammatory Response Syndrome, Systemic

cimetidine has been researched along with Inflammatory Response Syndrome, Systemic in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Olson, D1
Pohlman, A1
Hall, JB1
Tayama, E1
Hayashida, N1
Fukunaga, S1
Tayama, K1
Takaseya, T1
Hiratsuka, R1
Aoyagi, S1

Trials

2 trials available for cimetidine and Inflammatory Response Syndrome, Systemic

ArticleYear
Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creatinine clearance.
    American journal of respiratory and critical care medicine, 1996, Volume: 154, Issue:6 Pt 1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cimetidine; Creatinine; Cross-Over Studies; Diure

1996
High-dose cimetidine reduces proinflammatory reaction after cardiac surgery with cardiopulmonary bypass.
    The Annals of thoracic surgery, 2001, Volume: 72, Issue:6

    Topics: Aged; C-Reactive Protein; Cardiopulmonary Bypass; Cimetidine; Coronary Artery Bypass; Dose-Response

2001